*  Picarro Introduces A Hydrogen Peroxide Gas Concentration Analyzer For GMP Pharmaceutical Manufacturing Applications | BioSpace

... to help avoid oxidation and safeguard drug stability in high-potency API and biologics manufacturing and in aseptic fill and ... Industry (733) * Hotbed/Location (448,771) * Career Advice (2,943) Picarro Introduces A Hydrogen Peroxide Gas Concentration ...

*  PharmaGossip: Europe: New Device and Diagnostics Legislation Could Shake Up the Drug Industry

Europe: New Device and Diagnostics Legislation Could Shake Up the Drug Industry ... blog.pharmexec.com/2013/09/18/europe-new-device-and-diagnostics-legislation-could-shake-up-the-drug-industry/? ... New Device and Diagnostics Legislation Will Shake Up Drug IndustryThe shockwaves from the current European Union debates in ... diagnostics and the future of the drugs industry roll onwards. And as they roll, they are likely to start rolling very soon ...

*  2016 United States Alzheimer's Disease Drug Industry Review: Reportstack

The Alzheimer's Disease Drug industry development trends and marketing channels are analyzed. Finally the feasibility of new ... To view the table of contents and know more details please visit United States Alzheimer's Disease Drug Industry 2016 Market ... This report is a professional and in-depth study on the current state of the Alzheimer's Disease Drug industry. ... 7 Analysis of Alzheimer's Disease Drug Industry Key Manufacturers 7.1 Eisai 7.1.1 Company Profile 7.1.2 Product Picture and ...

*  Psychiatric Group Faces Scrutiny Over Drug Industry Ties - The New York Times

Probing into the financial relationship between drug companies and psychiatrists, senators are demanding that the American ... Psychiatric Group Faces Scrutiny Over Drug Industry Ties. By BENEDICT CAREY and GARDINER HARRIS. JULY 12, 2008. ... In 2006, the latest year for which numbers are available, the drug industry accounted for about 30 percent of the association's ... Psychiatric Association Faces Senate Scrutiny Over Drug Industry Ties. Order Reprints, Today's Paper,Subscribe ...

*  Serotonin, depression, and aggression - The problem of brain energy.

This is partly because of the involvement of the drug industry, but the U.S. government also played a role in setting a pattern ... This is partly because of the involvement of the drug industry, but the U.S. government also played a role in setting a pattern ... And in the case of the serotonin/antiserotonin mythology, this war has been rewarding to the drug industry--Lilly makes over $2 ... Theories based on transmitter substances and receptors are favored by the drug industry, but that kind of thinking is hardly ...

*  Election 2016 FAQ: Proposition 61, prescription drug costs | 89.3 KPCC

But there is real uncertainty in terms of how the pharmaceutical industry itself would respond. If this measure cuts into their ... Drug companies also might raise prices on the VA in response to Proposition 61, or refuse to offer the state the lowest price. ... Sometimes the VA works out special pricing with drug companies that is not made public. The state may not be able to find some ... Proposition 61 tries to reduce prescription drug costs by tying what state pays to what the VA Department pays.. The basics. ...

*  Mycoplasma Testing Market worth $613.49 Million by 2019: MarketsandMarkets

The growth in pharmaceutical industry and government funding for drug discovery and life sciences are important reasons for the ... This high growth rate, along with the substantial size of R&D spending on drug discovery projects, will act as an important ... It is the fastest growing area of the industry. According to estimates from the IMS Institute of Healthcare Informatics, the ... Increased research and development spending by pharmaceutical and biotechnology companies aided by increasing drug development ...

*  China Natural Sex Drug, Natural Sex Drug Manufacturers, Suppliers | Made-in-China.com

Select 2017 high quality Natural Sex Drug products in best price from certified Chinese Natural Product manufacturers, Sex ... Light Industry & Daily Use Powder No (36) Yes (712) Customized Non-Customized (458) Customized (290) Certification GMP (535) ... Chemical Drug Natural Fruit Pharmaceutical Drug Drug Packing Sex Product For Male Adult Sex Product Male Sex Male Sex Products ... Oral Drug Anti Drug Sex Products For Women Sex Powder Sex Enhancement Sex Penis Natural Pills ...

*  Global Immunotherapy Drug Industry 2016 Market Research Report : ReportsnReports

The Global Immunotherapy Drug Industry 2016 Market Research Report is... ... Check for Discount on Global Immunotherapy Drug Industry 2016 Market Research Report report by QYResearch Group. ... Global Immunotherapy Drug Industry 2016 Market Research Report Table of Contents 1 Industry Overview of Immunotherapy Drug 1.1 ... 1.4 Industry Chain Structure of Immunotherapy Drug 1.5 Industry Overview and Major Regions Status of Immunotherapy Drug 1.5.1 ...

*  Meningitis Outbreak: Restoring Confidence in the Drug Industry - ABC News

... the drug delivery system is once again coming under scrutiny and has been threatened with loss of confidence. ... Meningitis Outbreak: Restoring Confidence in Drug Industry. Peer-reviewed publications are the standard of excellence in the ... Meningitis Outbreak: Restoring Confidence in Drug Industry. Though the systems for insuring the credibility of scientific ... Not that long ago, you could walk into a drug store and be pretty certain that the non-prescription drug you took from the ...

*  pharmaceutical industry | Britannica.com

The modern era of the pharmaceutical industry-of isolation... ... Drug discovery and development*Drug development process. *Drug ... pharmaceutical industry: The discovery, development, and manufacture of drugs and medications (pharmaceuticals) by public and ... For a comprehensive description about the practice of medicine and the role of drug research in the health care industry, see ... The Perils of Industry: 10 Notable Accidents and Catastrophes. The fires of industry have long been stoked with sweat and toil ...

*  Pharmaceutical Market Research Reports: Human Reproductive Technologies Market Trends 2013 - 2019

For testosterone deficiency which is one of the major infertility causes in male patients, AndroGel is the blockbuster drug ... and Teva Pharmaceutical Industries Ltd. dominate the human reproductive technologies market. ... The infertility treatment market is characterized by the presence of many leading patented drug brands which are restraining ... The infertility drugs market studied in this report include leading brands from three drug classes, namely, gonadotropins, ...

*  Study Finds Real Cause of Alzheimer s Disease

The study may revive a long-running debate over whether the drug industry is focusing on the right target in developing ... The study from the Mayo Clinic may revive a long-running debate over whether the drug industry is focusing on the right target ... Biogen's drug BIIB037 and several others focus instead on the buildup of different set of protein fragments, called beta ... TauRx Pharmaceuticals Ltd., a closely held, Singapore-based drug developer, is testing a tau-targeting compound in broader ...

*  AIDS Initiative Will Tap Two From Drug Industry for Key Jobs - WSJ

The International AIDS Vaccine Initiative plans to appoint two senior pharmaceutical-industry officials to key scientific and ... said it plans to appoint two senior pharmaceutical-industry officials to key scientific and management posts today. ...

*  Medical Ethics and Research with the Elderly

The Pharmaceutical Research and Manufacturers of America (PhRMA), the drug industry s lobbying arm, adopted a voluntary code in ... Two tendencies appear to be injuring relationships between medicine and the drug industry. First, companies may frequently ... the drug was outstandingly safe. ' When reports of nerve and muscle disorders were reported the drug company labeled the ... a prominent diabetes expert leaked an article critical of the diabetes drug Avandia to the manufacturer of the drug, ...

*  Alzheimer Disease Drugs China Market Major Manufacturers, Trends, Demand, Share Analysis to 2021 | Medgadget

In the two past decades, the industry has ... This study focuses on China's Alzheimer Disease Drugs industry ... Molecular Robots to Build Drug Molecules. Laser Monitors Mitochondria to Predict Cardiac Arrest. Beyond Gaming: How Osso VR is ... China Alzheimer Disease Drugs Industry. This study focuses on China's Alzheimer Disease Drugs industry forecasts. In the two ... industry bureaus, industry publications, and our in-house databases. ...

*  News for Medical Independent Sales Representatives and Medical Distributors: Tobira Therapeutics Inc. Completes $31 Million...

Healthcare Industry News: Bristol-Myers Squibb Biopharmaceuticals HIV/AIDS Venture Capital Personnel News Release - August 1, ... TAK-652, a potentially "best in class" drug and TAK-220 are CCR5 antagonists that can be administered orally and bind to CCR5 ... and elegant methods in a leadership role at GlaxoSmithKline and was involved in evaluating HIV disease status and drug efficacy ... has launched several HIV/AIDS agents worldwide during his 23 year career in the biotechnology and pharmaceutical industry. ...
salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2019764&key=Bristol-Myers Squibb

*  Drug Industry Must Develop Reasonable Prices - WSJ

The point is not the amount of research conducted by the drug industry. The point is pricing in the U.S. market. Mr. Taurel ... 3 editorial-page commentary 'Hands Off My Industry' gave me symptoms of acute deja vu. Lilly officials used this same line of ... They failed miserably then, and they will fail fighting prescription drug importation with the same outdated ammunition. ... reasoning in the late 1970s when they fought generic drug substitution. ...

*  How a Shadow Drug Industry Tries to Avoid Regulation | HuffPost

Now some members of Congress are trying to reign in this shadow drug industry by giving the FDA the authority to regulate these ... But the industry is fighting back, using its political clout to resist federal standards. Like most industries in this ... the lobby group for this wing of the drug industry. Another IACP official, David Miller, warned that FDA regulations would " ... "strangle the industry." A coalition of nine pharmacy organizations -- in reality, drug companies -- claimed that the ...

*  Ellen Brown on the Drug Industry's Health Politics

Ellen Brown discusses the link between big banks and the drug industry, and how health politics go. ... The drug industry-the patent remedy industry-was in competition with the natural herbal remedies, and the homeopathic remedies ... The Links Between Big Banks and the Drug Industry Two good primers if you want to learn more about the banking system and the ... If you just treat symptoms like the drug model is doing, the industry makes obscene profits while the public health continues ...

*  Prescription drug industry needs to be reined in

Drug company profits and drive for aggrandization, that's how.. The Wall Street Journal, in the very same issue (Dec. 15, 2012 ... How have the drug companies fared with this investment? In exchange for investing millions over the decades in "medical ... There have been plenty of short-term studies funded by drug companies, but they are on the order of four to 12 weeks. These ... Because of drug company funding of talks, lectures, symposia, medical school grants and generous funds from pharmaceutical ...

*  HNRPM Antibody (monoclonal) (M01) - Mouse monoclonal antibody raised against a partial recombinant HNRPM. WB, IF, E - Buy Now!...

We supply quality antibodies and related products drug discovery and academic laboratories worldwide. Our focus is on targets ... and medical device industries, acquired Abgent in October of 2011. ... Abgent offers an energetic, friendly environment and the opportunity to further scientific research and drug discovery. Abgent ...

*  Anti-Rat Nestin Antibody, clone Rat-401 (4D4) - Mouse Anti-Rat Monoclonal Antibody WB, IHC-P, IHC-F, IF - Buy Now! |Abgent

We supply quality antibodies and related products drug discovery and academic laboratories worldwide. Our focus is on targets ... and medical device industries, acquired Abgent in October of 2011. ... Abgent offers an energetic, friendly environment and the opportunity to further scientific research and drug discovery. Abgent ...

*  10 Unexpected Home Uses for Mayonnaise

I don't know about the other ones but from working in the plant care industry for several years the last thing I would do is ... I tried all the products that the local drug stores had to offer and found that nothing worked. Afraid of killing more brain ...

*  Applications in Human Resource Management: Cases, Exercises, and Skill Builders - Stella M. Nkomo, Myron D. Fottler, R. Bruce...

He has written 20 books, including numerous recent books focused on HR and strategic thinking for the healthcare industry. He ... asked assigned Assistant Bank Bill Winthrop Committee company's continued crew leader develop Director discrimination drug test ...

(1/1252) Revolving drug funds: a step towards health security.

The establishment of a revolving drug fund project in Viet Nam is described and the factors responsible for its success are considered. As well as being a tool for cost recovery a revolving drug fund can serve as an entry point for strengthening health care and improving health security at local and district level.  (+info)

(2/1252) Sales practices of patent medicine sellers in Nigeria.

A survey was carried out among patent medicine dealers to evaluate their practices that militate against laws governing prescriptions-only medicines in Nigeria. Questionnaires were distributed to 46 patent medicine dealers and later collected from them on appointment. Analysis of the results showed that all the patent medicine dealers were aware of the law governing the sale of prescription drugs in Nigeria. Seventy-five per cent of them stock such drugs. Patent medicine dealers obtain their drugs largely from sales representative of pharmaceutical companies as well as from industries. Inappropriate use of sales boys and girls in patent medicine stores and defective government policies were all investigated.  (+info)

(3/1252) Hospitals and managed care: catching up with the networks.

Although the growth of managed care is having a significant impact on hospitals, organizational response to managed care remains fragmented. We conducted a survey of 83 hospitals nationwide that indicated that most hospitals now have at least one person devoted to managed care initiatives. These individuals, however, often spend most of their time on current issues, such as contracting with managed care organizations and physician relations. Concerns for the future, such as network development and marketing, although important, receive less immediate attention form these individuals. Hospital managed care executives must take a more proactive role in long range managed care planning by collaborating with managed care organizations and pharmaceutical companies.  (+info)

(4/1252) The challenge of integrating monoclonal antibodies into the current healthcare system.

Although there are few monoclonal antibody (MoAb) products on the market, the biotechnology industry has made considerable progress over the last decade. The industry has developed new technology to address the primary hurdles facing the development of MoAbs--including the immune response to murine-derived antibodies as well as lack of tumor specificity. As the techniques for development become more refined, more products will be approved by the Food and Drug Administration. Integrating these products into the existing healthcare system will be a challenge, given their high acquisition costs. Recent pharmacoeconomic examples outlined in this paper confirm that MoAb products will need to be supported with proven clinical and economic profiles. As long as a global clinical and economic perspective is taken and patient care benefits can be demonstrated, the place of MoAbs in the future of healthcare will be assured.  (+info)

(5/1252) Sale of drugs and health care utilization in a health care district in Zaire.

Health centres of Idjwi district (Zaire) have been self-financed through the selling of drugs since 1985. Medical care is expensive and its use is low (24 visits per year per 100 inhabitants). In 1989 the medical team tried to reduce the cost of visits by changing the prices of drugs and prescriptions. A limited control was set up to assess this intervention. The study showed that although prescribed drug costs were stabilized compared to inflation, there was no increase in the use of medical care. Moreover, the reduction of drug profit margins for health centres seriously affected the health care institution by causing a drop in income. Six months after the intervention the monthly accounts showed a deficit in 6 centres out of 8. The need for health care centres to be self-financing is a major limiting factor in the use of health care in Idjwi district. There are no easy solutions for health centre managers that satisfy both low-cost access to care and health care self-financing. Some minimal financial participation from the state is required. Only then can the concept of financing health care through the selling of drugs be operational.  (+info)

(6/1252) Managed care guidelines for the economic evaluation of pharmaceuticals.

Foundation Health Corporation, through its National Pharmacy and Therapeutics Committee, requires all pharmaceutical manufacturers and others who wish products to be considered for formulary listing to meet evidentiary and analytical standards in their submission documentation. This article details the evidentiary and analytical standards required from those making submissions and describes the methodological basis of the guidelines. This is the first time, as far as the authors are aware, that a managed care health system in the United States has required formulary submissions not only to meet clinical and economic evaluation standards, but also to take explicit account of the perspective of the managed care group in applying these techniques. Submissions are required to take what is described as a systems impact perspective. This approach is quite different, in both evidentiary and analytical terms, from standards required by health systems in other countries and standards for the economic evaluation of pharmaceuticals proposed by expert groups in the United States.  (+info)

(7/1252) Three countries' experience with Norplant introduction.

Despite international efforts to plan for Norplant introduction, the method has drawn the attention of critics of family planning programmes, and has raised several issues for debate since it was introduced into family planning programmes. The experiences of three countries with the introduction of Norplant highlight some of the unique features of the method that have affected its introduction. Indonesia, Bangladesh and the United States represent diverse cultural settings and systems of family planning provision. Experience in each country has highlighted the need to focus on quality of care for clients, most notably the need for good counselling and attention to removal as well as insertion. The cost of Norplant also has influenced its introduction in each country. Another issue includes the need to work with women's health advocacy groups, which is illustrated particularly in Bangladesh. Finally, the role of litigation in the United States, and its potential role in influencing Norplant introduction in other countries, is discussed. These three countries' experience illustrate the importance of understanding the programmatic context of contraceptive introduction.  (+info)

(8/1252) Outcomes research: collaboration among academic researchers, managed care organizations, and pharmaceutical manufacturers.

Medical and pharmaceutical outcomes research has been of increasing interest in the past 10 to 15 years among healthcare providers, payers, and regulatory agencies. Outcomes research has become a multidisciplinary field involving clinicians, health services researchers, epidemiologists, psychometricians, statisticians, psychologists, sociologists, economists, and ethicists. Collaboration among researchers in different organizations that offer different types of services and various research expertise is the essential element for any successful outcomes project. In this article we discuss collaboration on outcomes research among academic researchers (mainly those who work in colleges of pharmacy), managed care organizations, and research-based pharmaceutical manufacturers, with a focus on the opportunities and challenges facing each party. The pharmaceutical industry needs information to make product and promotion decisions; the managed care industry has data to offer but needs analysis of these data; and pharmacy schools, among other academic institutions, have skilled researchers and data-processing capacity but require projects for revenue, research training, experience, and publications. Challenges do exist with such endeavors, but collaboration could be beneficial in satisfying the needs of the individual parties.  (+info)


  • United States Alzheimer's Disease Drug Industry 2016 Market Research Report ‚Äč is a new market research publication announced by Reportstack. (pitchengine.com)

tobacco industry

  • Over the last half century, the tobacco industry has earned billions of dollars in profits by selling a deadly and addictive product while denying its harmfulness. (bmj.com)
  • The report finds that when forced to take legally binding positions, the tobacco industry still does not accept scientific consensus about the harms of their products. (bmj.com)
  • A leading critic of the tobacco industry took his anti-smoking message to the town's middle school Tuesday, using his offbeat humor to drive home the dangers of an addictive drug. (courant.com)
  • the tobacco industry is without question one of the most nefarious industries ever allowed in our country. (courant.com)
  • U.S. Rep. Barbara B. Kennelly was endorsed for governor Monday by a prominent anti-tobacco crusader -- state Attorney General Richard Blumenthal -- and said she would stop accepting campaign contributions from the tobacco industry. (courant.com)
  • I will not be accepting tobacco industry money," said Kennelly, a Democrat whose 20-town central Connecticut district includes her hometown of Hartford. (courant.com)
  • A consumer group started by Ralph Nader is on the attack against U.S. Rep. Gary A. Franks, R-5th District, for accepting campaign money from the tobacco industry and for opposing federal regulations aimed at reducing smoking by children. (courant.com)
  • Before legislators ban smoking in public buildings, the tobacco industry wants to have its consultant analyze the air at the State Capitol and Legislative Office Building to demonstrate that the ban is unnecessary. (courant.com)
  • Highlighting a new legal trend in the tobacco wars, two Connecticut construction unions sued the tobacco industry Tuesday to recover money spent treating tobacco-related illnesses of their members. (courant.com)

chain structure

  • The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. (pitchengine.com)


  • While much excitement has been generated surrounding evidence-based medicine, internal documents from the pharmaceutical industry suggest that the publicly available evidence base may not accurately represent the underlying data regarding its products. (springer.com)
  • The Pharmaceutical Research and Manufacturers of America (PhRMA), the drug industry s lobbying arm, adopted a voluntary code in 2002 that dealt with the appropriateness of gifts and payments from the drug industry to. (therubins.com)
  • 7/15/15 )- In this article we have written about the ethical practices of the medical and pharmaceutical industries, but the stock brokerage industry has had ethical questions also. (therubins.com)

major leading industry

  • The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. (pitchengine.com)


  • Many of the drug companies and medical device manufacturers have been reporting those figures on their websites for several years now, but any medical company that has any dealings with Medicare or Medicaid will have to report the amounts to the federal agency. (therubins.com)


  • In 2012, Pfizer Inc., the largest in revenue of all the drug companies, paid $173.2 million to U.S. health-care professionals. (therubins.com)


  • As criticism of the industry has accelerated in recent years, and calls for product regulation have grown, tobacco companies have defended themselves by saying they are now "responsible" corporations that aim to communicate honestly about their products. (bmj.com)


  • The Alzheimer's Disease Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. (pitchengine.com)
  • The Immunotherapy Drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. (reportsnreports.com)


  • Using Medicare Open Payments data, researchers collected data on 279,699 doctors who received 63,524 payments reported by the drug companies. (therubins.com)


  • The industry and its associated medical communication firms state that publications in the medical literature primarily serve marketing interests. (springer.com)
  • 6/22/16)- As we noted in our item dated 8/27/13 below, under the terms of the Affordable Care Act of 2010, there is a provision requiring drug and medical-device companies to report to the federal government detail. (therubins.com)


  • This report is a professional and in-depth study on the current state of the Alzheimer's Disease Drug industry. (pitchengine.com)
  • With 151 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. (pitchengine.com)


  • The PI2114 analyzer provides continuous, real-time measurement of hydrogen peroxide levels as low as 3.3 parts-per-billion (ppb) to help avoid oxidation and safeguard drug stability in high-potency API and biologics manufacturing and in aseptic fill and finish. (biospace.com)


  • A test of whether the industry has reformed is the truthfulness of company statements made under penalty of sanction in a court of law. (bmj.com)